For nearly two decades, Rob has served in a variety of roles, leading and advising corporations, nonprofits, institutions of higher education, and state entities. Before being appointed CEO he served as president and chief operating officer at Vektor, where he led clinical, regulatory, engineering, and operations. Rob is a former partner at Vorys, Sater, Seymour and Pease LLP and a former Deputy Solicitor General for the State of Ohio. He had the privilege of clerking for the Honorable R. Guy Cole of the United States Court of Appeals for the Sixth Circuit. Rob earned his JD from Harvard Law School.
Doug has over 25 years of executive-level finance, technology, risk management, and investment experience spanning more than 20 different industries. He was a founding partner in one of the first electronic derivative trading firms, a director and member of the Investment and Risk Committee, taught futures and options theory, has been a small business mentor, a CEO Coach, and has served on several boards in various roles, including managing a multi-asset class P.E. fund. Doug earned his B.S. from Indiana University Bloomington.
Dr. Christopher Villongco has over a decade of experience in computational modeling and high-performance computing. He conducted doctoral and post-doctoral research in the Departments of Bioengineering and Medicine at the University of California, San Diego. His work focused on developing and applying patient-specific computational models of cardiac electrophysiology to solve real-world clinical problems, especially heart failure and arrhythmias.
Joe is a seasoned commercial leader with over 15 years of experience leading startups across the artificial intelligence (AI), consumer technology, and healthcare industries. Most notably, he was served as Chief Marketing Officer leading go-to market strategy for the British AI technology startup SwiftKey, which was acquired by Microsoft in 2016 for $250 million. He leads Vektor's strategic partnerships and business development. Joe earned his M.A. in Law from the University of Cambridge and completed an M.P.A. fellowship at Brown University.
Emily brings over a decade of marketing experience to the Vektor team, transforming the way companies engage with markets and customers. Prior to joining Vektor, Emily worked for Etsy.com where she had a successful track record leading international marketing, branding initiatives and integrated communications campaigns. Emily has a wealth of experience across multiple fields including FMCG, finance, and technology. She holds a BSc Honors from Loughborough University, UK.
Averee is a certified ASQ Software Quality engineer with nearly a decade of experience in New Product Introduction - focusing on compliance, quality, validation and research. She earned her B.S. in Bioengineering from the University of California, Berkeley.
Christian has extensive experience as a machine learning-focused biomedical engineer and researcher. Most recently he was an AI research scientist at the Icahn School of Medicine & the Friedman Brain Institute at Mount Sinai, where he modeled biological data with artificial neural networks and built brain-inspired machine learning algorithms. He earned his Ph.D. in Bioengineering from Imperial College London and his B.A. from Princeton University, and conducted research at the Max-Planck Institute, the Princeton Neuroscience Institute, and the National Institutes of Health (NIH).
Maurice brings over 20 years of legal experience and more than a decade of technical experience to Vektor. His practice focuses on protecting the inventions of companies by analyzing their technologies, developing strategies for protecting their inventions, and implementing those strategies in the U.S. and internationally. Maurice has been responsible for achieving the issuance of over a thousand patents throughout his career. He also advises on infringement, invalidity, litigation, valuation, due diligence, and acquisition issues.
Dr. David Krummen is a professor of medicine at the University of California San Diego and the director of electrophysiology at the VA San Diego Healthcare System. He is a recognized expert in cardiac arrhythmia research. He pioneered ventricular fibrillation electrical substrate ablation, and has authored over 90 papers in the field.
Dr. Gordon Ho is an assistant professor of medicine at the University of California San Diego. He has more than 10 years of experience in computational modeling, ventricular fibrillation, and atrial fibrillation. Dr. Ho was recently awarded National Institutes of Health and American Heart Association career development grants to study the mechanisms of atrial fibrillation.
Dr. Andrew McCulloch is Distinguished Professor of Bioengineering and Medicine and the Shu Chien Chancellor's Endowed Chair in Engineering and Medicine at UC San Diego. He is also Director of the Institute of Engineering in Medicine which has 13 centers and over 200 faculty members. His laboratory has pioneered the use of multi-scale computational modeling both for elucidating the molecular mechanisms of heart disease and for patient-specific diagnosis and therapy planning in the clinical management of cardiac arrhythmias, heart failure, and congenital heart diseases.
Dr. John Miller has led the clinical cardiac electrophysiology group at the Indiana University School of Medicine since 1998. He is widely recognized as an expert in catheter and intraoperative mapping and ablation of ventricular tachyarrhythmias. Dr. Miller has authored more than 200 scientific publications and has served on many national committees.
Dr. Haines is Professor of Cardiovascular Medicine at Oakland University-William Beaumont School of Medicine, and the Director of the Heart Rhythm Center at Beaumont Health in Royal Oak, MI. He had focused his research career on understanding the biophysics and pathophysiology of catheter ablation lesion formation. He has been actively involved in the field of AF ablation experimentation since 1992, and was PI of the first multicenter pilot study of catheter ablation of AF in man (MECA Trial). Presently Dr. Haines is a Trustee for the Heart Rhythm Society (HRS), chair of the Cardiovascular Board Clinical Cardiac Electrophysiology Exam Com
Dr. Greg Feld is a Professor of Medicine at UCSD and an internationally recognized expert in cardiac electrophysiology. He serves as Director of the Cardiac Electrophysiology Program and Director of the Cardiac Electrophysiology Fellowship Training Program at UCSD.
Dr. McPherson is a board-certified EP and Clinical Professor of Medicine at Yale. He directed the Cardiology Care Unit and Electrophysiology Service at the VAMC, West Haven, CT from 1983 until 1992, when he moved to Bridgeport Hospital to develop the EP Service there. In 1995, he became the Director of the Cardiology Fellowship Program and is presently the longest serving Cardiology program director in the USA. Dr. McPherson served as chapter President and representative to the ACC Board of Governors from 2020 through 2023.
Dr. Birgersdotter-Green is a Professor of Medicine at UCSD and the Director of Pacemaker and ICD Services. She has extensive experience in the design and conduct of clinical trials. Dr. Birgersdotter-Green also serves on the Editorial Review Board for Heart Rhythm and the Journal of the American College of Cardiology.
Mrs. Janssen has 25+ years of senior leadership experience in the medical technology industry. She led Philips Medical Systems/EPD Solutions as General Manager/Business Leader since 2019. From 2014-2019, Mrs. Janssen served as President of Biotronik Inc. As Vice President at St. Jude Medical she made her mark by leading the charge on multiple industry-first product launches. In her career, she has led teams around the world across commercial, R&D, operations, clinical, marketing, and sales. She is internationally recognized for pioneering and launching industry first innovations.
Mike is a recognized senior executive with over 20 years of leadership and management experience in the life science, biotech, and diagnostics industries. Mike has built and led successful teams responsible for upwards of $200M in global revenue. Mike co-founded Vektor in 2017 and led the company through development and launch of its first product before moving into his role as executive chairman. Prior to co-founding Vektor, Mike held executive positions at Life Technologies, Serologicals and, most recently, at Sequenom where he played an integral role in the successful sale of its Biosciences division to Telegraph Hill Partners.
Russell is the president and CEO of the multi-billion-dollar investment enterprise, Redhill Investment Management, and its related companies. Russell has held key positions in national and global companies in both Private Equity and Real Estate Investment. Russell is an accomplished leader and businessman and has deep experience in investment and finance.
9255 Towne Centre Drive, St 750
San Diego, CA 92121
Issaquah,
WA 98027